The Honest Answers.
Frequently asked.
Daily Guidance lives in the app. If a signal needs attention, Laymen can send a short message that explains what changed, why it matters, what is missing, and what to do next.
No. The point is continuity, not engagement. Quiet weeks stay quiet. When something deserves attention, you get one clear message instead of streaks, badges, or noise.
No. Laymen is a health guidance system built from available signals. It does not diagnose, prescribe, or provide emergency care; medical decisions remain yours and your clinician's.
Genome is not generally available yet. We are treating it as the deepest context layer in Laymen, so it will not open until consent, encryption, review, and deletion controls are ready.
Baseline works with Apple Health on iPhone today. Android support - via Health Connect - is in private beta and ships in summer 2026. Wearable integrations are platform-agnostic.
Tell us in onboarding or by replying. Laymen treats those contexts as important, may ask for more information, and will not contradict your care team.
Terms is free. Baseline pricing is being finalized before launch. Genome will come later as an add-on once the lab partnership and review path are ready.
Yes. When Baseline subscriptions open, you will be able to cancel from billing settings or support. If you join a reserve list before paid access opens, there is no subscription to cancel.
A small team in Boston with backgrounds in genomics, clinical informatics, and consumer software. We are building the missing health layer directly for people, which means the product has to win on usefulness, trust, and follow-through.